Evaluation of the EsteR Toolkit for COVID-19 Decision Support: Sensitivity Analysis and Usability Study.
COVID-19
decision support tool
public health
sensitivity analysis
usability study
web application
Journal
JMIR formative research
ISSN: 2561-326X
Titre abrégé: JMIR Form Res
Pays: Canada
ID NLM: 101726394
Informations de publication
Date de publication:
27 Jun 2023
27 Jun 2023
Historique:
received:
05
12
2022
accepted:
15
05
2023
revised:
14
05
2023
medline:
27
6
2023
pubmed:
27
6
2023
entrez:
27
6
2023
Statut:
epublish
Résumé
During the COVID-19 pandemic, local health authorities were responsible for managing and reporting current cases in Germany. Since March 2020, employees had to contain the spread of COVID-19 by monitoring and contacting infected persons as well as tracing their contacts. In the EsteR project, we implemented existing and newly developed statistical models as decision support tools to assist in the work of the local health authorities. The main goal of this study was to validate the EsteR toolkit in two complementary ways: first, investigating the stability of the answers provided by our statistical tools regarding model parameters in the back end and, second, evaluating the usability and applicability of our web application in the front end by test users. For model stability assessment, a sensitivity analysis was carried out for all 5 developed statistical models. The default parameters of our models as well as the test ranges of the model parameters were based on a previous literature review on COVID-19 properties. The obtained answers resulting from different parameters were compared using dissimilarity metrics and visualized using contour plots. In addition, the parameter ranges of general model stability were identified. For the usability evaluation of the web application, cognitive walk-throughs and focus group interviews were conducted with 6 containment scouts located at 2 different local health authorities. They were first asked to complete small tasks with the tools and then express their general impressions of the web application. The simulation results showed that some statistical models were more sensitive to changes in their parameters than others. For each of the single-person use cases, we determined an area where the respective model could be rated as stable. In contrast, the results of the group use cases highly depended on the user inputs, and thus, no area of parameters with general model stability could be identified. We have also provided a detailed simulation report of the sensitivity analysis. In the user evaluation, the cognitive walk-throughs and focus group interviews revealed that the user interface needed to be simplified and more information was necessary as guidance. In general, the testers rated the web application as helpful, especially for new employees. This evaluation study allowed us to refine the EsteR toolkit. Using the sensitivity analysis, we identified suitable model parameters and analyzed how stable the statistical models were in terms of changes in their parameters. Furthermore, the front end of the web application was improved with the results of the conducted cognitive walk-throughs and focus group interviews regarding its user-friendliness.
Sections du résumé
BACKGROUND
BACKGROUND
During the COVID-19 pandemic, local health authorities were responsible for managing and reporting current cases in Germany. Since March 2020, employees had to contain the spread of COVID-19 by monitoring and contacting infected persons as well as tracing their contacts. In the EsteR project, we implemented existing and newly developed statistical models as decision support tools to assist in the work of the local health authorities.
OBJECTIVE
OBJECTIVE
The main goal of this study was to validate the EsteR toolkit in two complementary ways: first, investigating the stability of the answers provided by our statistical tools regarding model parameters in the back end and, second, evaluating the usability and applicability of our web application in the front end by test users.
METHODS
METHODS
For model stability assessment, a sensitivity analysis was carried out for all 5 developed statistical models. The default parameters of our models as well as the test ranges of the model parameters were based on a previous literature review on COVID-19 properties. The obtained answers resulting from different parameters were compared using dissimilarity metrics and visualized using contour plots. In addition, the parameter ranges of general model stability were identified. For the usability evaluation of the web application, cognitive walk-throughs and focus group interviews were conducted with 6 containment scouts located at 2 different local health authorities. They were first asked to complete small tasks with the tools and then express their general impressions of the web application.
RESULTS
RESULTS
The simulation results showed that some statistical models were more sensitive to changes in their parameters than others. For each of the single-person use cases, we determined an area where the respective model could be rated as stable. In contrast, the results of the group use cases highly depended on the user inputs, and thus, no area of parameters with general model stability could be identified. We have also provided a detailed simulation report of the sensitivity analysis. In the user evaluation, the cognitive walk-throughs and focus group interviews revealed that the user interface needed to be simplified and more information was necessary as guidance. In general, the testers rated the web application as helpful, especially for new employees.
CONCLUSIONS
CONCLUSIONS
This evaluation study allowed us to refine the EsteR toolkit. Using the sensitivity analysis, we identified suitable model parameters and analyzed how stable the statistical models were in terms of changes in their parameters. Furthermore, the front end of the web application was improved with the results of the conducted cognitive walk-throughs and focus group interviews regarding its user-friendliness.
Identifiants
pubmed: 37368487
pii: v7i1e44549
doi: 10.2196/44549
pmc: PMC10337391
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e44549Informations de copyright
©Rieke Alpers, Lisa Kühne, Hong-Phuc Truong, Hajo Zeeb, Max Westphal, Sonja Jäckle. Originally published in JMIR Formative Research (https://formative.jmir.org), 27.06.2023.
Références
Emerg Infect Dis. 2020 Nov;26(11):2598-2606
pubmed: 33035448
J Infect Dev Ctries. 2020 Apr 30;14(4):323-327
pubmed: 32379707
Eur Respir J. 2020 Jun 4;55(6):
pubmed: 32366488
BMC Med Inform Decis Mak. 2010 Jul 22;10:40
pubmed: 20650007
J Med Virol. 2022 Sep;94(9):4156-4169
pubmed: 35524338
Front Public Health. 2021 Jan 08;8:577431
pubmed: 33490015
J Korean Med Sci. 2020 Aug 10;35(31):e288
pubmed: 32776726
Influenza Other Respir Viruses. 2021 Jan;15(1):19-26
pubmed: 32767657
New Microbes New Infect. 2020 Jul;36:100715
pubmed: 32566233
Int J Infect Dis. 2021 Mar;104:708-710
pubmed: 33548553
J Int Med Res. 2020 Sep;48(9):300060520956834
pubmed: 32967488
Comput Biol Med. 2023 May;158:106794
pubmed: 37044045
BMJ Open. 2020 Aug 16;10(8):e039652
pubmed: 32801208
Int J Infect Dis. 2020 Jun;95:391-398
pubmed: 32339715
Aging Med (Milton). 2020 May 22;3(2):102-109
pubmed: 32661509
Am J Trop Med Hyg. 2020 Oct;103(4):1608-1613
pubmed: 32815514
Int J Environ Res Public Health. 2021 Jan 31;18(3):
pubmed: 33572542
J Infect Public Health. 2021 May;14(5):638-646
pubmed: 33848893
Epidemiol Health. 2020;42:e2020007
pubmed: 32035431
Clin Infect Dis. 2020 Nov 19;71(16):2099-2108
pubmed: 32392331
N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
Int J Environ Health Res. 2022 Aug;32(8):1707-1715
pubmed: 33818217
Results Phys. 2021 Mar;22:103956
pubmed: 33623733
Emerg Infect Dis. 2021 May;27(5):1486-1491
pubmed: 33900189
BMC Infect Dis. 2020 Jul 20;20(1):526
pubmed: 32689956
IEEE J Biomed Health Inform. 2022 Jun;26(6):2458-2468
pubmed: 35452393
PLoS Negl Trop Dis. 2022 Jan 5;16(1):e0010048
pubmed: 34986169
China CDC Wkly. 2020 Jul 03;2(27):491-495
pubmed: 34594686
Sustain Cities Soc. 2021 Jan;64:102559
pubmed: 33101882
Epidemiol Infect. 2020 Sep 02;148:e197
pubmed: 32873357
Lancet Infect Dis. 2020 Aug;20(8):911-919
pubmed: 32353347
Infection. 2022 Aug;50(4):803-813
pubmed: 34409563
Biometrics. 2021 Sep;77(3):929-941
pubmed: 32627172
Epidemiol Infect. 2021 Sep 22;149:e213
pubmed: 34549699
Int J Infect Dis. 2021 Oct;110 Suppl 1:S28-S43
pubmed: 34332082
J Biomed Inform. 2019 Mar;91:103110
pubmed: 30721757
Nat Commun. 2021 Mar 9;12(1):1533
pubmed: 33750783
East Mediterr Health J. 2021 Aug 26;27(8):745-754
pubmed: 34486710
Epidemics. 2021 Sep;36:100482
pubmed: 34175549
Int J Infect Dis. 2020 Apr;93:284-286
pubmed: 32145466
Emerg Infect Dis. 2021 Mar;27(3):924-927
pubmed: 33434475
Int J Environ Res Public Health. 2021 Aug 31;18(17):
pubmed: 34501757
Clin Infect Dis. 2021 Dec 16;73(12):2344-2352
pubmed: 34117868
Transbound Emerg Dis. 2020 Nov;67(6):2860-2868
pubmed: 32473049
Epidemiol Infect. 2021 Mar 02;149:e65
pubmed: 33650470
J Epidemiol Glob Health. 2021 Mar;11(1):55-59
pubmed: 32959618
Sci Adv. 2020 Aug 14;6(33):eabc1202
pubmed: 32851189
Medicine (Baltimore). 2021 Dec 3;100(48):e27846
pubmed: 35049185
J Infect Dev Ctries. 2021 Mar 31;15(3):389-397
pubmed: 33839714
J Clin Med. 2020 Feb 17;9(2):
pubmed: 32079150
Euro Surveill. 2020 Apr;25(16):
pubmed: 32347198
Ann Intern Med. 2020 Aug 18;173(4):262-267
pubmed: 32422057
J Med Internet Res. 2020 Oct 12;22(10):e19994
pubmed: 33001833
Epidemiol Health. 2020;42:e2020035
pubmed: 32512664
Nat Med. 2020 May;26(5):672-675
pubmed: 32296168
Emerg Infect Dis. 2022 Mar;28(3):756-759
pubmed: 35107418
Transbound Emerg Dis. 2020 Nov;67(6):2818-2822
pubmed: 32452648
J Med Internet Res. 2021 Apr 16;23(4):e26645
pubmed: 33750740
Epidemiol Infect. 2020 Jun 19;148:e117
pubmed: 32594928
JMIR Public Health Surveill. 2020 Oct 15;6(4):e22678
pubmed: 33001839
Stud Health Technol Inform. 2022 Aug 17;296:17-24
pubmed: 36073484
Med J Aust. 2003 Jul 7;179(1):34-7
pubmed: 12831382
Risk Manag Healthc Policy. 2020 Aug 11;13:1111-1117
pubmed: 32848488
Chaos Solitons Fractals. 2020 Jul;136:109889
pubmed: 32406395
PLoS One. 2022 Jul 11;17(7):e0270789
pubmed: 35816497
J Infect Dis. 2021 Nov 22;224(10):1664-1671
pubmed: 34423821
PeerJ. 2021 Feb 25;9:e10992
pubmed: 33665041
Environ Health Prev Med. 2021 Jan 18;26(1):10
pubmed: 33461491
Dtsch Arztebl Int. 2020 Nov 13;117(46):790-791
pubmed: 33533714